Hemispherx BioPharma (HEB)

[bd2004]

PHILADELPHIA, May 15, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma,
Inc. (NYSE Amex:HEB) stated that in view of the unusual market
activity in the Company's stock, the NYSE Amex has contacted the
Company and requested that the Company issue a public statement
indicating as to whether there are any corporate developments which
may explain the unusual activity. The Company stated that there have
been no material events other than as disclosed in its recent press
releases and its filings with the Securities and Exchange Commission
that would explain the high volume market activity.

http://money.cnn.com/news/newsfeeds/...ire/165572.htm